81_FR_54258 81 FR 54101 - Request for Nominations on the Tobacco Products Scientific Advisory Committee

81 FR 54101 - Request for Nominations on the Tobacco Products Scientific Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 157 (August 15, 2016)

Page Range54101-54102
FR Document2016-19312

The Food and Drug Administration (FDA) is requesting that any industry organizations interested in participating in the selection of a nonvoting member to represent the interests of tobacco growers to serve on the Tobacco Products Scientific Advisory Committee for the Center for Tobacco Products (CTP), notify FDA in writing. FDA is also requesting nominations for a nonvoting member to represent the interests of tobacco growers to serve on the Tobacco Products Scientific Advisory Committee, and an alternate to this representative. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice.

Federal Register, Volume 81 Issue 157 (Monday, August 15, 2016)
[Federal Register Volume 81, Number 157 (Monday, August 15, 2016)]
[Notices]
[Pages 54101-54102]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Request for Nominations on the Tobacco Products Scientific 
Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any 
industry organizations interested in participating in the selection of 
a nonvoting member to represent the interests of tobacco growers to 
serve on the Tobacco Products Scientific Advisory Committee for the 
Center for Tobacco Products (CTP), notify FDA in writing. FDA is also 
requesting nominations for a nonvoting member to represent the 
interests of tobacco growers to serve on the Tobacco Products 
Scientific Advisory Committee, and an alternate to this representative. 
A nominee may either be self-nominated or nominated by an organization 
to serve as a nonvoting industry representative. Nominations

[[Page 54102]]

will be accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent the interests 
of tobacco growers must send a letter stating that interest to FDA by 
September 14, 2016 (see sections I and II of this document for further 
details). Concurrently, nomination materials for prospective candidates 
should be sent to FDA by September 14, 2016.

ADDRESSES: All statements of interest from industry organizations 
interested in participating in the selection process should be sent to 
Caryn Cohen (see FOR FURTHER INFORMATION CONTACT). All nominations for 
nonvoting industry representatives should be submitted electronically 
by accessing the FDA Advisory Committee Membership Nomination Portal 
at: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail to Advisory Committee Oversight and Management 
Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 
32, Rm. 5103, Silver Spring, MD 20993-0002. Information about becoming 
a member of an FDA advisory committee can also be obtained by visiting 
FDA's Web site at: http://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center 
for Tobacco Products, Food and Drug Administration, Center for Tobacco 
Products, Document Control Center, Bldg. 71, Rm. G335, 10903 New 
Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-287-1373 (choose 
Option 5), email: [email protected].

SUPPLEMENTARY INFORMATION: The Agency intends to add nonvoting industry 
representatives to the following advisory committee:

I. Tobacco Products Scientific Advisory Committee

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of Food and Drugs (the Commissioner) or 
designee in discharging responsibilities related to the regulation of 
tobacco products. The Committee reviews and evaluates safety, 
dependence, and health issues relating to tobacco products and provides 
appropriate advice, information, and recommendations to the 
Commissioner.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent the interests 
of tobacco growers should send a letter stating that interest to the 
FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days of 
publication of this document (see DATES). Within the subsequent 30 
days, FDA will send a letter to each organization that has expressed an 
interest, attaching a complete list of all such organizations, and a 
list of all nominees along with their current r[eacute]sum[eacute]s. 
The letter will also state that it is the responsibility of the 
interested organizations to confer with one another and to select a 
candidate, within 60 days after the receipt of the FDA letter, to serve 
as the nonvoting member to represent the interests of tobacco growers 
for the committee. The interested organizations are not bound by the 
list of nominees in selecting a candidate. However, if no individual is 
selected within 60 days, the Commissioner will select the nonvoting 
member to represent the interests of tobacco growers.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting member to represent the 
interests of tobacco growers. Contact information, current curriculum 
vitae, and the name of the committee of interest should be sent to the 
FDA Advisory Committee Membership Nomination Portal (see ADDRESSES) 
within 30 days of publication of this document (see DATES). FDA will 
forward all nominations to the organizations expressing interest in 
participating in the selection process for the committee. (Persons who 
nominate themselves as nonvoting industry representatives will not 
participate in the selection process.)
    FDA seeks to include the views of women, and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore encourages nominations of 
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 9, 2016.
Janice M. Soreth,
Acting Associate Commissioner, Special Medical Programs.
[FR Doc. 2016-19312 Filed 8-12-16; 8:45 am]
 BILLING CODE 4164-01-P



                                                                             Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices                                                  54101

                                                   • Confidential Submissions—To                        FOR FURTHER INFORMATION CONTACT:                      document. Please use the document
                                                submit a comment with confidential                      Jismi Johnson, Center for Devices and                 number 1835 to identify the guidance
                                                information that you do not wish to be                  Radiological Health, Food and Drug                    you are requesting.
                                                made publicly available, submit your                    Administration, 10903 New Hampshire
                                                                                                                                                              IV. Paperwork Reduction Act of 1995
                                                comments only as a written/paper                        Ave., Bldg. 66, Rm. 1524, Silver Spring,
                                                submission. You should submit two                       MD 20993–0002, 301–796–6424.                            This guidance refers to previously
                                                copies total. One copy will include the                 SUPPLEMENTARY INFORMATION:                            approved collections of information.
                                                information you claim to be confidential                                                                      These collections of information are
                                                                                                        I. Background                                         subject to review by the Office of
                                                with a heading or cover note that states
                                                ‘‘THIS DOCUMENT CONTAINS                                   FDA has developed this guidance                    Management and Budget (OMB) under
                                                CONFIDENTIAL INFORMATION.’’ The                         document to assist industry in preparing              the Paperwork Reduction Act of 1995
                                                Agency will review this copy, including                 premarket notification (510(k))                       (44 U.S.C. 3501–3520). The collections
                                                the claimed confidential information, in                submissions for electrosurgical devices               of information in 21 CFR part 807,
                                                its consideration of comments. The                      intended for use in general surgery.                  subpart E have been approved under
                                                                                                        These devices are designed to cut and/                OMB control number 0910–0120; the
                                                second copy, which will have the
                                                                                                        or remove tissue and control bleeding                 collections of information in 21 CFR
                                                claimed confidential information
                                                                                                        through the use of high-frequency                     part 820 have been approved under
                                                redacted/blacked out, will be available
                                                                                                        electrical current. For the purpose of                OMB control number 0910–0073; the
                                                for public viewing and posted on http://
                                                                                                        this guidance, electrosurgical devices                collections of information in 21 CFR
                                                www.regulations.gov. Submit both
                                                                                                        may also be called radiofrequency                     part 801 have been approved under
                                                copies to the Division of Dockets                                                                             OMB control number 0910–0485; and
                                                Management. If you do not wish your                     devices or high-frequency devices. The
                                                                                                        scope of this document is limited to the              the collections of information in the
                                                name and contact information to be                                                                            guidance document ‘‘Requests for
                                                                                                        class II electrosurgical devices and
                                                made publicly available, you can                                                                              Feedback on Medical Device
                                                                                                        accessories classified under 21 CFR
                                                provide this information on the cover                                                                         Submissions: The Pre-Submission
                                                                                                        878.4400, Electrosurgical cutting and
                                                sheet and not in the body of your                                                                             Program and Meetings with Food and
                                                                                                        coagulation device and accessories.
                                                comments and you must identify this                        In the Federal Register of March 24,               Drug Administration Staff’’ have been
                                                information as ‘‘confidential.’’ Any                    2014 (79 FR 16008), FDA announced the                 approved under OMB control number
                                                information marked as ‘‘confidential’’                  availability of the draft guidance.                   0910–0756.
                                                will not be disclosed except in                         Interested persons were invited to                      Dated: August 9, 2016.
                                                accordance with 21 CFR 10.20 and other                  comment by June 23, 2014. A total of six
                                                applicable disclosure law. For more                                                                           Leslie Kux,
                                                                                                        sets of comments were received. FDA                   Associate Commissioner for Policy.
                                                information about FDA’s posting of                      reviewed and considered all the public
                                                comments to public dockets, see 80 FR                                                                         [FR Doc. 2016–19404 Filed 8–12–16; 8:45 am]
                                                                                                        comments received and revised sections
                                                56469, September 18, 2015, or access                    of the guidance, where applicable.                    BILLING CODE 4164–01–P
                                                the information at: http://www.fda.gov/
                                                regulatoryinformation/dockets/                          II. Significance of Guidance
                                                default.htm.                                               This guidance is being issued                      DEPARTMENT OF HEALTH AND
                                                                                                        consistent with FDA’s good guidance                   HUMAN SERVICES
                                                   Docket: For access to the docket to
                                                read background documents or the                        practices regulation (21 CFR 10.115).                 Food and Drug Administration
                                                electronic and written/paper comments                   The guidance represents the current
                                                                                                        thinking of FDA on premarket                          [Docket No. FDA–2016–N–0001]
                                                received, go to http://
                                                www.regulations.gov and insert the                      notification (510(k)) submissions for
                                                                                                        electrosurgical devices for general                   Request for Nominations on the
                                                docket number, found in brackets in the                                                                       Tobacco Products Scientific Advisory
                                                heading of this document, into the                      surgery. It does not establish any rights
                                                                                                        for any person and is not binding on                  Committee
                                                ‘‘Search’’ box and follow the prompts
                                                and/or go to the Division of Dockets                    FDA or the public. You can use an                     AGENCY:    Food and Drug Administration,
                                                Management, 5630 Fishers Lane, Rm.                      alternative approach if it satisfies the              HHS.
                                                1061, Rockville, MD 20852.                              requirements of the applicable statutes               ACTION:   Notice.
                                                                                                        and regulations.
                                                   An electronic copy of the guidance                                                                         SUMMARY:   The Food and Drug
                                                document is available for download                      III. Electronic Access                                Administration (FDA) is requesting that
                                                from the Internet. See the                                 Persons interested in obtaining a copy             any industry organizations interested in
                                                SUPPLEMENTARY INFORMATION section for                   of the guidance may do so by                          participating in the selection of a
                                                information on electronic access to the                 downloading an electronic copy from                   nonvoting member to represent the
                                                guidance. Submit written requests for a                 the Internet. A search capability for all             interests of tobacco growers to serve on
                                                single hard copy of the guidance                        Center for Devices and Radiological                   the Tobacco Products Scientific
                                                document entitled ‘‘Premarket                           Health guidance documents is available                Advisory Committee for the Center for
                                                Notification (510(k)) Submissions for                   at http://www.fda.gov/MedicalDevices/                 Tobacco Products (CTP), notify FDA in
                                                Electrosurgical Devices for General                     DeviceRegulationandGuidance/                          writing. FDA is also requesting
                                                Surgery’’ to the Office of the Center                   GuidanceDocuments/default.htm.                        nominations for a nonvoting member to
                                                Director, Guidance and Policy                           Guidance documents are also available                 represent the interests of tobacco
sradovich on DSK3GMQ082PROD with NOTICES




                                                Development, Center for Devices and                     at http://www.regulations.gov. Persons                growers to serve on the Tobacco
                                                Radiological Health, Food and Drug                      unable to download an electronic copy                 Products Scientific Advisory
                                                Administration, 10903 New Hampshire                     of ‘‘Premarket Notification (510(k))                  Committee, and an alternate to this
                                                Ave., Bldg. 66, Rm. 5431, Silver Spring,                Submissions for Electrosurgical Devices               representative. A nominee may either be
                                                MD 20993–0002. Send one self-                           for General Surgery’’ may send an email               self-nominated or nominated by an
                                                addressed adhesive label to assist that                 request to CDRH-Guidance@fda.hhs.gov                  organization to serve as a nonvoting
                                                office in processing your request.                      to receive an electronic copy of the                  industry representative. Nominations


                                           VerDate Sep<11>2014   19:23 Aug 12, 2016   Jkt 238001   PO 00000   Frm 00061   Fmt 4703   Sfmt 4703   E:\FR\FM\15AUN1.SGM   15AUN1


                                                54102                        Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices

                                                will be accepted for current vacancies                  growers should send a letter stating that             DEPARTMENT OF HEALTH AND
                                                effective with this notice.                             interest to the FDA contact (see FOR                  HUMAN SERVICES
                                                DATES: Any industry organization                        FURTHER INFORMATION CONTACT) within
                                                interested in participating in the                      30 days of publication of this document               Food and Drug Administration
                                                selection of an appropriate nonvoting                   (see DATES). Within the subsequent 30
                                                member to represent the interests of                    days, FDA will send a letter to each                  [Docket No. FDA–2014–D–0218]
                                                tobacco growers must send a letter                      organization that has expressed an
                                                stating that interest to FDA by                         interest, attaching a complete list of all            Premarket Notification Submissions
                                                September 14, 2016 (see sections I and                  such organizations, and a list of all                 for Bipolar Electrosurgical Vessel
                                                II of this document for further details).               nominees along with their current                     Sealers for General Surgery; Guidance
                                                Concurrently, nomination materials for                                                                        for Industry and Food and Drug
                                                                                                        résumés. The letter will also state that
                                                prospective candidates should be sent to                                                                      Administration Staff; Availability
                                                                                                        it is the responsibility of the interested
                                                FDA by September 14, 2016.                              organizations to confer with one another              AGENCY:    Food and Drug Administration,
                                                ADDRESSES: All statements of interest                   and to select a candidate, within 60                  HHS.
                                                from industry organizations interested                  days after the receipt of the FDA letter,
                                                in participating in the selection process                                                                     ACTION:   Notice of availability.
                                                                                                        to serve as the nonvoting member to
                                                should be sent to Caryn Cohen (see FOR
                                                                                                        represent the interests of tobacco                    SUMMARY:   The Food and Drug
                                                FURTHER INFORMATION CONTACT). All
                                                                                                        growers for the committee. The                        Administration (FDA or Agency) is
                                                nominations for nonvoting industry
                                                                                                        interested organizations are not bound                announcing the availability of the
                                                representatives should be submitted
                                                                                                        by the list of nominees in selecting a                guidance entitled ‘‘Premarket
                                                electronically by accessing the FDA
                                                                                                        candidate. However, if no individual is               Notification (510(k)) Submissions for
                                                Advisory Committee Membership
                                                                                                        selected within 60 days, the                          Bipolar Electrosurgical Vessel Sealers
                                                Nomination Portal at: https://
                                                                                                        Commissioner will select the nonvoting                for General Surgery.’’ FDA has
                                                www.accessdata.fda.gov/scripts/
                                                                                                        member to represent the interests of                  developed this guidance document to
                                                FACTRSPortal/FACTRS/index.cfm or by
                                                                                                        tobacco growers.                                      assist industry in preparing premarket
                                                mail to Advisory Committee Oversight
                                                                                                                                                              notification (510(k)) submissions for
                                                and Management Staff, Food and Drug                     III. Application Procedure                            bipolar electrosurgical vessel sealers
                                                Administration, 10903 New Hampshire
                                                                                                                                                              intended for use in general surgery.
                                                Ave., Bldg. 32, Rm. 5103, Silver Spring,                  Individuals may self-nominate and/or
                                                MD 20993–0002. Information about                                                                              DATES: Submit either electronic or
                                                                                                        an organization may nominate one or
                                                becoming a member of an FDA advisory                    more individuals to serve as a nonvoting              written comments on this guidance at
                                                committee can also be obtained by                                                                             any time. General comments on Agency
                                                                                                        member to represent the interests of
                                                visiting FDA’s Web site at: http://                                                                           guidance documents are welcome at any
                                                                                                        tobacco growers. Contact information,
                                                www.fda.gov/AdvisoryCommittees/                                                                               time.
                                                                                                        current curriculum vitae, and the name
                                                default.htm.                                            of the committee of interest should be                ADDRESSES: You may submit comments
                                                FOR FURTHER INFORMATION CONTACT:                        sent to the FDA Advisory Committee                    as follows:
                                                Caryn Cohen, Office of Science, Center                  Membership Nomination Portal (see                     Electronic Submissions
                                                for Tobacco Products, Food and Drug                     ADDRESSES) within 30 days of
                                                Administration, Center for Tobacco                                                                              Submit electronic comments in the
                                                                                                        publication of this document (see                     following way:
                                                Products, Document Control Center,                      DATES). FDA will forward all
                                                Bldg. 71, Rm. G335, 10903 New                                                                                   • Federal eRulemaking Portal: http://
                                                                                                        nominations to the organizations                      www.regulations.gov. Follow the
                                                Hampshire Ave., Silver Spring, MD                       expressing interest in participating in
                                                20993–0002, 1–877–287–1373 (choose                                                                            instructions for submitting comments.
                                                                                                        the selection process for the committee.              Comments submitted electronically,
                                                Option 5), email: TPSAC@fda.hhs.gov.                    (Persons who nominate themselves as                   including attachments, to http://
                                                SUPPLEMENTARY INFORMATION: The                          nonvoting industry representatives will               www.regulations.gov will be posted to
                                                Agency intends to add nonvoting                         not participate in the selection process.)            the docket unchanged. Because your
                                                industry representatives to the following
                                                                                                          FDA seeks to include the views of                   comment will be made public, you are
                                                advisory committee:
                                                                                                        women, and men, members of all racial                 solely responsible for ensuring that your
                                                I. Tobacco Products Scientific Advisory                 and ethnic groups, and individuals with               comment does not include any
                                                Committee                                               and without disabilities on its advisory              confidential information that you or a
                                                   The Tobacco Products Scientific                      committees and, therefore encourages                  third party may not wish to be posted,
                                                Advisory Committee (the Committee)                      nominations of appropriately qualified                such as medical information, your or
                                                advises the Commissioner of Food and                    candidates from these groups.                         anyone else’s Social Security number, or
                                                Drugs (the Commissioner) or designee in                                                                       confidential business information, such
                                                                                                          This notice is issued under the                     as a manufacturing process. Please note
                                                discharging responsibilities related to
                                                                                                        Federal Advisory Committee Act (5                     that if you include your name, contact
                                                the regulation of tobacco products. The
                                                                                                        U.S.C. app. 2) and 21 CFR part 14,                    information, or other information that
                                                Committee reviews and evaluates safety,
                                                                                                        relating to advisory committees.                      identifies you in the body of your
                                                dependence, and health issues relating
                                                to tobacco products and provides                          Dated: August 9, 2016.                              comments, that information will be
                                                                                                                                                              posted on http://www.regulations.gov.
sradovich on DSK3GMQ082PROD with NOTICES




                                                appropriate advice, information, and                    Janice M. Soreth,
                                                recommendations to the Commissioner.                                                                            • If you want to submit a comment
                                                                                                        Acting Associate Commissioner, Special
                                                                                                        Medical Programs.
                                                                                                                                                              with confidential information that you
                                                II. Selection Procedure                                                                                       do not wish to be made available to the
                                                                                                        [FR Doc. 2016–19312 Filed 8–12–16; 8:45 am]
                                                   Any industry organization interested                                                                       public, submit the comment as a
                                                in participating in the selection of an                 BILLING CODE 4164–01–P                                written/paper submission and in the
                                                appropriate nonvoting member to                                                                               manner detailed (see ‘‘Written/Paper
                                                represent the interests of tobacco                                                                            Submissions’’ and ‘‘Instructions’’).


                                           VerDate Sep<11>2014   19:23 Aug 12, 2016   Jkt 238001   PO 00000   Frm 00062   Fmt 4703   Sfmt 4703   E:\FR\FM\15AUN1.SGM   15AUN1



Document Created: 2016-08-13 02:21:57
Document Modified: 2016-08-13 02:21:57
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesAny industry organization interested in participating in the selection of an appropriate nonvoting member to represent the interests of tobacco growers must send a letter stating that interest to FDA by September 14, 2016 (see sections I and II of this document for further details). Concurrently, nomination materials for prospective candidates should be sent to FDA by September 14, 2016.
ContactCaryn Cohen, Office of Science, Center for Tobacco Products, Food and Drug Administration, Center for Tobacco Products, Document Control Center, Bldg. 71, Rm. G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-287-1373 (choose Option 5), email: [email protected]
FR Citation81 FR 54101 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR